|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-3-8
|
|
pubmed:abstractText |
The potential risk of transmission of porcine endogenous retroviruses (PERV) from xenogeneic donors into humans has been widely debated. Because we were involved in a phase I/II clinical trial using a bioartificial liver support system (BLSS), we proceeded to evaluate the biosafety of this device.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
420-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11884940-Animals,
pubmed-meshheading:11884940-Bioreactors,
pubmed-meshheading:11884940-Cell Line,
pubmed-meshheading:11884940-DNA, Viral,
pubmed-meshheading:11884940-Endogenous Retroviruses,
pubmed-meshheading:11884940-Hepatocytes,
pubmed-meshheading:11884940-Humans,
pubmed-meshheading:11884940-Liver, Artificial,
pubmed-meshheading:11884940-RNA, Viral,
pubmed-meshheading:11884940-RNA-Directed DNA Polymerase,
pubmed-meshheading:11884940-Safety,
pubmed-meshheading:11884940-Swine,
pubmed-meshheading:11884940-Virion
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus.
|
|
pubmed:affiliation |
Thomas E. Starzl Transplantation Institute, and the Department of Surgery, University of Pittsburgh Medical Center-Health System, Pittsburgh, Pennsylvania, USA.
|
|
pubmed:publicationType |
Journal Article
|
